USA 1984
seen from United States
seen from Italy
seen from Norway

seen from United States
seen from Switzerland
seen from Netherlands

seen from Malaysia

seen from United States

seen from Germany
seen from Türkiye
seen from Norway

seen from United States
seen from China
seen from Belarus

seen from Netherlands

seen from Malaysia

seen from Malaysia

seen from Chile

seen from Malaysia

seen from Netherlands
USA 1984
The global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030
Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic.
House passes biohazard preparation bill, sends to Obama
By Pete Kasperowicz - 03/04/13 06:53 PM ET
The House on Monday evening passed legislation that would reauthorize several programs meant to help develop medical countermeasures and take other steps to prepare for public health emergencies and biohazards, including possible terrorist attacks. Members approved H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act, in a 370-28 vote. All of of the "no" votes came from Republicans.
The House had approved nearly identical legislation in early February. Last week, the Senate approved it with what Rep. Joe Pitts (R-Pa.) called "minor changes." House passage sends the bill to the White House for President Obama's signature.
The US Department of Health and Human Services (HHS) today awarded contracts for the creation of three new centres tasked with responding to the threat of future pandemics and biological attacks. To be based in Maryland, North Carolina and Texas, the three centres are comprised of academic and industry consortia whose role it will be to hasten the development and manufacturing of vaccines and medications in the event of an emerging biological threat.
“Establishing these centers represents a dramatic step forward in ensuring that the United States can produce life-saving countermeasures quickly and nimbly,” said HHS Secretary Kathleen Sebelius in a statement on 18 June. “They will improve our ability to protect Americans’ health in an emergency and help fill gaps in preparedness so that our nation can respond to known or unknown threats.”